{
  "kind": "treatment",
  "slug": "flupentixol-depixol",
  "type": "antipsychotic",
  "name": "Flupentixol (Depixol)",
  "summary": "A typical antipsychotic of the thioxanthene class used in schizophrenia, other psychoses, and in some countries at low doses for depression and anxiety.",
  "description": "Flupentixol is a first-generation (typical) antipsychotic of the thioxanthene group. It primarily blocks dopamine D2 receptors in the mesolimbic pathway, reducing psychotic symptoms. At lower doses, it has antidepressant and anxiolytic properties. Available in oral and long-acting injectable formulations.",
  "category": "medications/antipsychotics",
  "tags": [
    "antipsychotic",
    "typical antipsychotic",
    "thioxanthene"
  ],
  "metadata": {
    "drug_classes": [
      "Typical Antipsychotic",
      "Thioxanthene"
    ],
    "therapeutic_categories": [
      "Psychosis",
      "Schizophrenia",
      "Depression",
      "Anxiety Disorders"
    ],
    "mechanism_categories": [
      "Dopamine Blocker"
    ],
    "administration_routes": [
      "Oral",
      "Injection"
    ],
    "prescription_status": "Prescription Required",
    "controlled_substance": false,
    "generic_available": true,
    "brand_names": [
      "Depixol",
      "Fluanxol"
    ],
    "dea_schedule": null,
    "fda_pregnancy_category": "C",
    "age_groups": [
      "Adult",
      "Geriatric"
    ],
    "treatment_duration": [
      "Long-term"
    ],
    "specialty_areas": [
      "Psychiatry"
    ],
    "fda_approval_year": 1965
  },
  "clinical_metadata": {
    "primary_indications": [
      "Psychosis"
    ],
    "off_label_uses": [
      "Depression (low dose)",
      "Anxiety disorders (low dose)"
    ],
    "contraindications": [
      "Coma",
      "CNS depression",
      "Pheochromocytoma",
      "Known hypersensitivity to flupentixol or other thioxanthenes"
    ],
    "monitoring_required": [
      "Extrapyramidal symptoms",
      "Metabolic profile",
      "ECG if cardiac risk factors"
    ],
    "efficacy_rating": {
      "schizophrenia": 4,
      "depression_low_dose": 2
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "flupentixol",
      "depixol",
      "fluanxol",
      "antipsychotic",
      "thioxanthene"
    ],
    "synonyms": [
      "flupenthixol"
    ],
    "common_misspellings": [
      "flupentixal",
      "flupentixole"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Schizophrenia",
        "Other psychotic disorders",
        "Low-dose use for depression and anxiety (outside US)"
      ]
    },
    {
      "type": "mechanism",
      "text": "Blocks dopamine D2 receptors in mesolimbic pathways, reducing positive psychotic symptoms; also antagonizes serotonin and adrenergic receptors to a lesser degree."
    },
    {
      "type": "dosing",
      "adult": {
        "oral_psychosis": "3–15 mg/day in divided doses; maintenance: 3–6 mg/day",
        "oral_low_dose": "0.5–3 mg/day for depression/anxiety (non-US use)",
        "depot": "20–40 mg IM every 2–4 weeks; adjust by response"
      },
      "geriatric": "Lower initial dose recommended",
      "hepatic_impairment": "Use with caution; adjust dose",
      "renal_impairment": "No specific adjustment, but use caution"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Tablets: 0.5 mg, 1 mg, 3 mg, 5 mg",
        "Depot injection (flupentixol decanoate): 20 mg/mL, 40 mg/mL"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Oral: improvement within days to weeks; depot: onset in 24–72 hours, duration up to 4 weeks."
    },
    {
      "type": "adverse_effects",
      "common": [
        "extrapyramidal symptoms",
        "drowsiness",
        "dry mouth",
        "constipation",
        "weight gain"
      ],
      "less_common": [
        "orthostatic hypotension",
        "hyperprolactinemia",
        "sexual dysfunction"
      ],
      "serious": [
        "tardive dyskinesia",
        "neuroleptic malignant syndrome",
        "QT prolongation"
      ]
    },
    {
      "type": "warnings",
      "black_box": "Increased mortality in elderly patients with dementia-related psychosis.",
      "other": [
        "Risk of extrapyramidal symptoms increases with dose",
        "Monitor for tardive dyskinesia with long-term use"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "CNS depressants",
          "risk": "Additive sedation",
          "action": "Use caution"
        },
        {
          "with": "QT-prolonging drugs",
          "risk": "Arrhythmia",
          "action": "Avoid or monitor"
        },
        {
          "with": "Levodopa",
          "risk": "Reduced efficacy of levodopa",
          "action": "Avoid combination"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "EPS and tardive dyskinesia signs",
        "Weight, glucose, lipids",
        "ECG if cardiac risk factors",
        "Mood and adherence"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Use only if benefits outweigh risks",
      "lactation": "Excreted in breast milk; use caution",
      "pediatrics": "Not recommended",
      "geriatrics": "More sensitive to adverse effects"
    },
    {
      "type": "tapering",
      "text": "Gradually reduce over weeks to months to prevent withdrawal dyskinesia or relapse."
    },
    {
      "type": "clinical_notes",
      "items": [
        "Depot formulation improves adherence in chronic psychosis",
        "Low-dose use for depression is not FDA-approved but used in some countries",
        "Thioxanthenes have similar profile to high-potency typical antipsychotics"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "Depixol Prescribing Information",
          "url": "https://www.medicines.org.uk/"
        },
        {
          "label": "Maudsley Prescribing Guidelines",
          "url": "https://www.wiley.com/"
        }
      ]
    }
  ],
  "seo": {
    "title": "Flupentixol (Depixol): Typical Antipsychotic Dosing & Side Effects",
    "description": "Flupentixol (Depixol) is a thioxanthene antipsychotic for schizophrenia and other psychoses, available in oral and depot forms."
  }
}
